Later studies in pediatric AML patients demonstrated that elevated IL-6 induced chemo-resistance and exacerbated disease progression through enhanced STAT3 activity, which was associated with a poor outcome [105]. The gene discussed is IL6; the disease is acute myeloid leukemia.